Company / Cash & Equivalents
QuidelOrtho Cash & Equivalents History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$169.8M
FY2025
5-year range
$98.3M / $169.8M
FY2023-FY2025
Trend
+72.7%
vs FY2024
Sector context
#91 of 152
Health Care
What the data says
At $170M, QuidelOrtho's cash & equivalents ranks #91 of 152 in the Health Care sector. Improved from $119M to $170M over the past 2 years.
Based on SEC 10-K filings.
$170M in FY2025.
Improved from $119M to $170M over the past 2 years.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#91 of 152 in Health CareTop 60% of 152This company $169.8M Sector average $1.2B
▼
-85.4% below sector average
Key checks
Key Insights
- In FY2025, cash & equivalents increased 72.7% year-over-year.
- Ranks #91 out of 152 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $169.8M | +72.7% |
| FY2024 | $98.3M | -17.3% |
| FY2023 | $118.9M | - |
| FY2022 | - | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026